ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Rhoads Presses For Greater Emphasis On Etiology In DNCP; Workshops Develop New Research Leads

July 16, 1976

Jackson Lab Win $9.5 Mil. Grant; Others Named

October 5, 1990

Literature Review Supports Need for More Research In Cancer Control

July 19, 1985

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

Cooperative Groups Start To Deploy Medidata Rave, Despite Contract Dispute

April 22, 2011